We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
(+17%)
Cap. Flow
+$2.63B
Cap. Flow
% of AUM
18.56%
Top 10 Holdings %
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$226M |
| 2 |
Microsoft
MSFT
|
+$205M |
| 3 |
Tesla
TSLA
|
+$83.2M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$65.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$64.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sociedad Química y Minera de Chile
SQM
|
+$60.4M |
| 2 |
Meta Platforms (Facebook)
META
|
+$39.1M |
| 3 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$36.9M |
| 4 |
Booking.com
BKNG
|
+$28M |
| 5 |
Stryker
SYK
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.77% |
| 2 | Technology | 24.47% |
| 3 | Financials | 9.64% |
| 4 | Consumer Discretionary | 7.95% |
| 5 | Industrials | 7.13% |
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2022 Portfolio in Review
As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.
- Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
- Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
- Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
- Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
- Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
- Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
- Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.
Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.